Status:
COMPLETED
Placebo Controlled Study of Sublingual Salvinorin A
Lead Sponsor:
California Pacific Medical Center Research Institute
Conditions:
Pharmaceutical Preparations
Eligibility:
All Genders
21-45 years
Phase:
NA
Brief Summary
In this study, our aim is to determine an active but tolerable sublingual dose (range 100 to 4000 µg) of Salvinorin A (SA) in experienced subjects. This study is an ascending-dose, placebo-controlled,...
Eligibility Criteria
Inclusion
- Male or female, aged 21-45
- Experienced with hallucinogenic amounts of SA
- Good physical and mental health
- Able to give adequate informed consent
Exclusion
- Any medical or psychiatric condition which, in the investigators' opinion, would preclude safe or consistent participation
- Significant acute or chronic medical disease
- Female who is pregnant, lactating, or plans to become pregnant during the study period and within one month after study drug administration
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT01149824
Start Date
June 1 2009
End Date
October 1 2010
Last Update
May 31 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.